Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,544 shares at $88.16 ($224K) on 2019-02-05, disclosed to the SEC on 2019-02-06.
Open-market sale of $224k NBIX by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.13 | 603 | $53K | 23.7% |
| 2 | $88.13 | 603 | $53K | 23.7% |
| 3 | $88.16 | 669 | $59K | 26.3% |
| 4 | $88.16 | 669 | $59K | 26.3% |
| Total | $88.15 avg | 2,544 | $224K | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |